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Next-generation sequencing has uncovered novel classes of small RNAs (sRNAs) in eukaryotes, in addition to the well-known
miRNAs, siRNAs, and piRNAs. In particular, sRNA species arise from transcription start sites (TSSs) and the transcription
termination sites (TTSs) of genes. However, a detailed characterization of these new classes of sRNAs is still lacking. Here, we
present a comprehensive study of sRNAs derived from TTSs of expressed genes (TTSa-RNAs) in human cell lines and primary
tissues. Taking advantage of sRNA-sequencing, we show that TTSa-RNAs are present in the nuclei of human cells, are loaded
onto both AGO1 and AGO2, and their biogenesis does not require DICER and AGO2 endonucleolytic activity. TTSa-RNAs
display a strong bias against a G residue in the first position at 5′ end, a known feature of AGO-bound sRNAs, and a peculiar
oligoA tail at 3′ end. AGO-bound TTSa-RNAs derive from genes involved in cell cycle progression regulation and DNA
integrity checkpoints. Finally, we provide evidence that TTSa-RNAs can be detected by sRNA-Seq in primary human tissue, and
their expression increases in tumor samples as compared to nontumor tissues, suggesting that in the future, TTSa-RNAs might
be explored as biomarker for diagnosis or prognosis of human malignancies.
1. Introduction
In the last ten years, the technologies for RNA profiling
strongly improved. These advances disclosed pervasive tran-
scription of more than 70% of the human genome, with
protein-coding genes accounting for less than 2% of the total
RNA [1]. Thus, a dominant portion of the transcribed regions
on the human genome originates from non-protein-coding
genes (noncoding RNAs (ncRNAs)). Increasing evidences
are being obtained, indicating that noncoding RNAs possess
essential regulatory functions and could be one of the major
contributors to the complex traits of the organisms [2].
Small RNAs (sRNAs) of~ 20–30 nucleotides (nt) consti-
tute a large family of ncRNAs that regulate gene expression.
Through base pairing, sRNAs recognize their complementary
RNAs as their targets and mediate posttranscriptional and/or
transcriptional silencing [3]. The best characterized sRNA
classes are microRNAs (miRNAs), small interfering RNAs
(siRNAs), and PIWI-interacting RNAs (piRNAs). All these
classes of sRNAs are loaded onto a member of Argonaute
family proteins. Argonaute proteins typically have a molecu-
lar weight of~ 100 kDa and can be divided into two subfam-
ilies: AGO subfamily (e.g., AGO1, AGO2, AGO3, and AGO4
in mammals) that binds to miRNAs and siRNAs and PIWI
subfamily (HIWI/PIWIL1, HILI/PIWIL2, HIWI2/PIWIL4,
and HIWI3/PIWIL3) that binds to piRNAs [4].
sRNA profiling by next-generation sequencing (sRNA-
Seq) is the method of choice for the identification of lowly
abundant sRNA classes, in addition to the miRNA, siRNA,
and piRNA families. Indeed, sRNAs with varying lengths of
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between 18 and 200 nucleotides have been reported to be
derived from specific genomic regions in higher eukaryotes.
At least three classes of sRNAs derived from regions mapping
around the 5′ termini of genes have been described: tran-
scription initiation RNAs (tiRNAs) [5], transcription start
site-associated RNAs (TSSa-RNAs) [6–8], and promoter-
associated small RNAs (PASRs) [9, 10]. The origin and
function of these RNAs are uncertain, but preliminary
evidence suggests that they are involved in epigenetic control
of gene expression. Recently it has been described a new
family of sRNAs, termed DNA damage-response RNAs
(DDRNAs) [11] or double-strand break- (DSB-) induced
RNAs (diRNAs) [12], that are generated at sites of DNA
damage and control the DNA damage response.
Finally, sRNA mapping around 3′ termini of genes of
higher eukaryotes have also been described, such as
termini-associated sRNAs (TASRs) [10, 13], antisense
TASRs (aTASRs) [14], and transcription termination site-
associated RNAs (TTSa-RNAs) [15]. These sRNA classes
can vary in length from 22 to 200nt and their biological
roles and mechanisms of biogenesis remain to be elucidated.
Over the years, sRNAs have become the focus of
biomarker research, an approach that has been favorably
used in the prediction and early detection of disease and in
the investigation of response to treatment for several medical
conditions. miRNAs are the most frequently assessed for
their potential role as biomarkers, such as in cancer [16], liver
[17], and cardiovascular disease [18] among many others.
Moreover, dysregulation of other sRNA species such as piR-
NAs, small nucleolar RNAs (snoRNAs), and small nuclear
RNAs (snRNAs) is being found to have relevance to tumori-
genesis, neurological, cardiovascular, developmental, and
other diseases [19]. Thus, they might be potentially assessed
as biomarkers of disease.
Here, we present a comprehensive characterization of
TTSa-RNAs [15] in human cells. We show that TTSa-RNAs
are present in both AGO1 and AGO2 complexes immuno-
purified from human cell nuclei. Moreover, TTSa-RNAs can
be detected in both soluble and chromatin-associated nuclear
extract. Biogenesis of this class of sRNAs is independent of
both DICER and AGO2 endonucleolytic activity. TTSa-
RNAs show a very strong bias against a G residue in the first
position at 5′ end, which is a specific feature of AGO-bound
sRNAs and a peculiar oligoA tail at 3′ end. Finally, AGO-
bound TTSa-RNAs derive from genes involved in cell cycle
progression regulation and DNA integrity checkpoints.
Interestingly, this class of sRNAs can be detected in primary
human tissues, and their expression increases in tumor
samples as compared to nontumor tissues.
2. Materials and Methods
2.1. Cell Culture and Transfection. HeLaS3 cells were grown
in DMEMmedium supplemented with 10% (v/v) fetal bovine
serum, 2mM L-glutamine and penicillin-streptomycin. HCT
116 WT and DICEREx5 cells [20] were grown in McCoy’s 5A
medium supplemented with 10% (v/v) fetal bovine serum,
2mM L-glutamine and penicillin-streptomycin.
HeLaS3 AGO2KO monoclonal cell line was obtained by
using two specific Zinc Finger Nucleases (ZNF1 and ZNF2,
CompoZr® Knockout Zinc Finger Nucleases, Sigma). HeLaS3
cells were plated in a 6-well plate and transfected using
Lipofectamine® 2000 (Thermo Fisher Scientific) with 1.5μg
of each ZNF expression plasmid. After two sequential trans-
fections with the AGO2-specific ZNF expression plasmids,
individual clones were isolated by serial dilution and assayed
by Western Blot and RT-qPCR for loss of AGO2 expression.
2.2. Nuclear Fractionation. Nuclear fractionation was per-
formed similar to [21]. 12 x 106 adherent HeLaS3 cells were
washed in 1xPBS and then recovered by scraping and centri-
fugation. Cell pellets were resuspended in 200μl of Buffer A
(10mM HEPES pH7.5, 10mM KCl, 10% glycerol, 340mM
sucrose, 4mM MgCl2, 1mM DTT,1 x Protease Inhibitor
Cocktail, Sigma), and then an equal volume of Buffer A with
0.2% (v/v) Triton X-100 was added and the mixture was
incubated on ice for 12 minutes to lyse cells, followed by cen-
trifugation (1200×g, 5min, 4°C). The crude nuclear pellet
was resuspended in 300μl NRB (20mM HEPES pH7.5,
50% glycerol, 75mM NaCl, 1mM DTT, 1 x protease inhibi-
tor cocktail), transferred to a microcentrifuge tube, and
centrifuged (500×g, 5min, 4°C) to wash. The pellet was
resuspended in 100μl NRB, and then an equal volume of
NUN buffer (20mM HEPES, 300mM NaCl, 1M urea, 1%
NP-40 Substitute, 10mM MgCl2, 1mM DTT, 1 x Protease
Inhibitor Cocktail) was added and incubated 5 minutes on
ice and then centrifuged (1200×g, 5min, 4°C). The soluble
nuclear extract supernatant was transferred to another tube,
and the depleted nuclear pellet was resuspended in 1ml
Buffer A to wash, transferred to another microcentrifuge
tube, and centrifuged (1200×g, 5min, 4°C). Resulting puri-
fied chromatin pellets were resuspended in 200μl Buffer A.
TriFast (0.6ml) (EuroClone) was added to 140μl of each
fraction. As a spike-in control, 2 fmol of a synthetic nonhu-
man microRNA (ath-miR-159a) was added to each fraction.
2.3. RNA Isolation and RT-qPCR. RNA from HeLa S3, HeLa
S3 AGO2KO, HCT 116 WT, and DICEREx5 cells, as well as
fractions from nuclear fractionation protocol, was isolated
using Direct-zol™ RNA MiniPrep Kit (Zymo Research)
according to the manufacturer’s protocol.
For RT-qPCR of AGO2, ACTB, and MALAT-1, RNA
was retrotranscribed using GoScript™ Reverse Transcriptase
and random primers (Promega). Quantitative real-time PCR
was performed using GoTaq® qPCR Master Mix (Promega).
Primer sequences are as follows:
AGO2F ggaggtctgtaacattgtgg, AGO2R gcaatagctttatttc
ctgccc; ACTB F cctggcacccagcacaat, ACTB R gggccggactcgt
catact; and MALAT-1 F aaagcaaggtctccccacaag, MALAT-1
R ggtctgtgctagatcaaaaggca.
TTSa-RNA (Table 1) expression was checked by using
Custom TaqMan® Small RNA Assay (Thermo Fisher
Scientific). RNA was retrotranscribed using SuperScript II
Reverse Transcriptase (Thermo Fisher Scientific), and qPCR
was performed using iTaq Universal Probes Supermix
(Bio-Rad). Quantification was normalized to small nucleolar
RNA U44 (for total RNA) or to ath-miR-159a spike-in
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(for SNE and CPE fractions), amplified by TaqMan Small
RNA Assay (Thermo Fisher Scientific).
2.4. Western Blot. For Western blot analyses, the following
antibodies were used: anti-AGO2 (11A9, Millipore), anti-
Histone H3 antibody (FL-136, Santa Cruz), anti-BAF155
(Abcam), antibeta Tubulin (Sigma).
2.5. Small RNA Sequencing. sRNA-Seq was performed from
total RNA isolated from HeLaS3 and AGO2KO HeLaS3 cells
by IGA TECH (Udine, Italy). Library was prepared using
TruSeq Small RNA Library Preparation Kit (Illumina).
Sequencing was performed on HiSeq 2500 in a 50 bp single-
read mode 10 million reads/sample. It is worth pointing out
that the protocol we applied to generate sRNA libraries only
captures 5′ phosphorylated RNA molecules and does not
allow cloning of sRNAs harboring a 5′Cap.
2.6. TTSa-RNA Data Analysis from Cell Lines. RNA Immu-
noprecipitation and next-generation sequencing were per-
formed as previously published [6, 22]. NGS data quality
was checked using FastQC. tRNA and rRNA genomic coor-
dinates on hg38 genome were retrieved from UCSC Repeat-
Masker track [23] using Table Browser tool [24]. By using
bedtools [25], tRNA and rRNA sequences in FASTA format
were retrieved from hg38 genome sequence and used to build
a bowtie1 [26] reference index for tRNA and rRNA. miRNA
hairpin FASTA sequence was downloaded from miRbase
(v21) [27], and human hairpins were extracted. Using bow-
tie-build, a bowtie1 index was obtained for miRNA hairpins.
Each FASTQ file was processed as follows:
(1) Adapter sequences were removed using cutadapt;
only reads longer than 17nt were retained.
(2) Adapter-cleaned reads were aligned to the above-
mentioned miRNA hairpin bowtie1 index using
bowtie1 with -n 2 -l 18 options.
(3) Reads without any valid alignment in step 2 were
aligned to the abovementioned tRNA and rRNA
bowtie1 index with -n 2 -l 18 options.
(4) Reads without any valid alignment in step 3 were
aligned to hg38 human reference with bowtie1 with
-n 0 -l 18 -m 1 options. Only reads with a single valid
alignment were investigated further.
TTSa-RNAs were defined as those reads aligned in step 4,
with at least 1 nt overlapping a 5nt-long window centered on
genomic coordinates of polyA sites (GENCODE v24, [26]).
Only polyA sites with a 1 nt length were taken into account
in all the analyses (99.8% of the 48535 polyA sites reported
by GENCODE v24 annotation).
Within each sample, RPM was defined as the number of
reads divided by the total number of reads that gave at least
one valid alignment in either step 2, 3, or 4 of the alignment
procedure ∗ 106.
3′ tails of TTSa-RNAs and miRNAs were determined
using Tailor v1.1 [28].
2.7. PAR-CLIP Data Analysis. PAR-CLIP libraries were
analyzed using the same pipeline outlined above.
2.8. Read Coverage Plots. Cumulative coverage of sRNAs giv-
ing rise to a single alignment in step 4 was computed using
bedtools in a window of 1000 nt centered on GENCODE
v24 polyA sites. Each sRNA contributed to the coverage of
the closest polyA site only. Three polyA sites (# 605212,
627827, and 582464) lying within 500 nt of loci giving rise
to very large numbers of small RNA molecules (not-overlap-
ping any polyA site) were omitted to obtain a clearer picture.
For PAR-CLIP datasets, only reads harboring a
single mismatch to the reference genome were used to
compute coverage.
2.9. GO Term Analysis. Ensembl GENE IDs were retrieved
from GENCODE v24 annotation. Genes giving rise to
TTSa-RNAs were defined as any Ensembl GENE overlapping
a single TTSa-RNA. GO term analysis was performed on
DAVID [29] by submitting the list of Ensembl GENE IDs
overlapped by TTSa-RNA in each sample. As background,
the entire set of Ensembl GENE IDs was used. The reported
GO terms were obtained by selecting GO_term_BP_4 in
the DAVID output and downloading the full table.
Significantly enriched GO terms (FDR< 0.01) were
sorted for decreasing “Fold Enrichment” and the Fold
Enrichment was plotted for the top 10 GO Terms.
2.10. Correlation of mRNA Expression with TTSa-RNA
Counts. mRNA expression in HeLaS3 was retrieved from
ENA: EXR352930, EXR352926. Reads were pseudoaligned
to the human transcriptome, and transcripts were quantified
in transcript per million (TPM) using Kallisto v 0.43.1
[30]. Ensembl GENE IDs corresponding to the Ensembl
Table 1: Sequences of TTSa-RNAs selected for RT-qPCR analysis.
TTSa-RNA Sequence (5′-> 3′)
Rank of TTSa-RNAs associated to each gene based
on their abundance in each library
HeLaS3
AGO2-IP
HeLaS3
AGO1-IP
HCT116
AGO2-IP
BUB3_TTSa-RNA CTAATAAACGAGATGCAGAACCCT 4 4 3
WEE1_TTSa-RNA CATATTAAAAGTCACTCTGAGCT 13 13 15
PSMB1_TTSa-RNA TTTATTAAAAGAGAAACCTGAAG 26 39 8
CDKNA1_TTSa-RNA CTCAATAAATGATTCTTAGTGACT 47 32 21
YWHAG_TTSa-RNA CAGTGACGAGGAACTCCCGAGA 86 47 101
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TRANSCRIPT IDs were retrieved using BioMart, and the
TPM for all transcripts of each gene were summed, giving
a summarized TPM value for each gene. The genes with
TPM below the first tertile were filtered out.
mRNA expression in 44 adrenocortical carcinoma
primary samples was retrieved from GEO repository
(GSE49278) and belongs to the same samples whose sRNA-
seq were used for TTSa-RNA quantification as described
below. The Affymetrix Human Gene 2.0 ST Array was
analyzed in R (R package version 1.58.1) using Bioconductor
packages oligo [31] and genefilter (using RMA as a back-
ground correction/normalization/summarization method).
Genes with RMA expression values below the first tertile in
more than 10 samples were filtered out; the PROBEIDs were
mapped to Ensembl GENE IDs and the Ensembl GENE IDs
mapped more than once (<10%) were excluded.
mRNA expression in 10 kidney tumor samples and 10
matched controls was retrieved from SRA project
SRP003901 and belongs to the same samples whose sRNA-
seq were used for TTSa-RNAs quantification. The digital
gene expression (DGE) sequencing reads were trimmed from
Illumina adapters using cutadapt [32], resulting in 17 nt
reads, which were mapped using bowtie1 with -p 8 -v 0 -m
2 options, after adding the four nucleotides of NlaIII
restriction site to the 5′ of each read. The DGE tags belonging
to each transcript were quantified using htseq-count [33]
(with intersection-strict option) and the htseq-counts were
normalized using DESeq package [34]. Genes with no counts
in more than the 10% of samples and genes with normalized
counts below the first tertile were filtered out.
The correlations were computed using custom R scripts
and the R2 was computed from a Spearman correlation
coefficient. In all cases, the genes with TTSa-RNA RPM in
the first three quartiles were filtered out, because this
corresponded to less than 4 TTSa-RNA reads per sample.
2.11. TTSa-RNAs Data Analysis from Primary Samples. A
search in SRA was performed using miRNA and cancer/
tumor as keywords. We retrieved 17 datasets containing
sRNA-seq data for tumor tissue and matched controls. How-
ever, only 5 datasets were suitable for our analysis. In fact, we
discarded a dataset that was obtained in colorspace (it could
not be analyzed using our computational pipeline), a dataset
with a sudden drop in Phred quality (median Phred score = 2
for all positions> 16 in all samples), a dataset which
contained only one single healthy tissue control sample, three
datasets because all reads were shorter than 18nt (multiple
alignments on the genome did not allow specific identifica-
tion of TTSa-RNAs), and six datasets in which abundant
mRNA fragments with random size distribution were
retrieved among sRNA-seq reads, suggesting that mRNA
degradation does not allow proper identification of bona
fide TTSa-RNAs.
The 5 datasets analyzed correspond to SRA projects:
SRP028291, SRP014142, SRP045645, SRP003902, and
SRP048750. Analysis of these datasets was performed as
outlined above for AGO protein-bound sRNAs, except for
the application of an 18 to 26nt size filter as discussed in
the results and discussion section. All p values were
computed using Wilcoxon sum-rank test (a paired version
of the test was used for datasets containing paired normal
tissue and tumor tissue from each patient) using R function
wilcox.test (https://www.r-project.org/).
2.12. Availability of Data and Materials. The following
datasets analyzed during the current study are available in
the ENA repository:
(1) http://www.ebi.ac.uk/ena/data/view/ERX352930
(2) http://www.ebi.ac.uk/ena/data/view/ERX352926
(3) http://www.ebi.ac.uk/ena/data/view/ERX344794
(4) http://www.ebi.ac.uk/ena/data/view/ERX344797
(5) http://www.ebi.ac.uk/ena/data/view/ERX350060
(6) http://www.ebi.ac.uk/ena/data/view/ERX338767
(7) http://www.ebi.ac.uk/ena/data/view/ERX338764
The following datasets analyzed during the current study
are available in the SRA repository;
(1) https://trace.ncbi.nlm.nih.gov/Traces/sra/sra.cgi?stu
dy=SRP038925
(2) https://trace.ncbi.nlm.nih.gov/Traces/sra/?study=SR
P028291
(3) https://trace.ncbi.nlm.nih.gov/Traces/sra/sra.cgi?stu
dy=SRP014142
(4) https://trace.ncbi.nlm.nih.gov/Traces/sra/sra.cgi?stu
dy=SRP045645
(5) https://trace.ncbi.nlm.nih.gov/Traces/sra/sra.cgi?stu
dy=SRP003902
(6) https://trace.ncbi.nlm.nih.gov/Traces/sra/sra.cgi?stu
dy=SRP048750
(7) https://trace.ncbi.nlm.nih.gov/Traces/sra/?run=SRR
650321
(8) https://trace.ncbi.nlm.nih.gov/Traces/sra/?run=SRR
650318
3. Results and Discussion
3.1. Nuclear AGO1 and AGO2 Bind a Class of sRNAs Arising
from Human Transcription Termination Sites. To obtain an
overview of nuclear sRNA classes bound to AGO proteins
in human cells, we reanalyzed a set of sRNA-seq libraries
generated by immunopurifying AGO1 and AGO2 from
nuclear extracts of HeLaS3 cell line [6]. We focused on less
characterized classes of AGO bound sRNAs, that is reads
not aligning to known human miRNAs (miRbase 21) or
human tRNAs and rRNAs. All the reads surviving to this
preliminary filtering were aligned to human hg38 reference
genome requiring unambiguous mapping to a unique
genomic position. Reads with multiple mappings on the
hg38 reference genome were not further investigated (see
Materials and Methods for details).
We found that in nuclei of human cells, both AGO1 and
AGO2 bind a class of sRNAs (21–24nt long, Figure 1(a))
arising from TTSs of human mRNA transcripts and
lying on the sense strand of the gene they arise from
(Figure 1(b)). Notably, 3′ end of these sRNAs in most cases
(60% to 66% depending on the dataset analysed) maps within
2nt of GENCODE-annotated polyA sites. We assumed that
these sRNAs belong to the class of TTSa-RNAs. Indeed,
TTSa-RNAs have been described as AGO1/2-associated,
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miRNA- (22–24nt) sized sRNAs whose 3′ends aligned with
the annotated polyadenylation sites and mapping on the
sense strand [15]. Another class of sRNA mapping around
3′ termini of genes has been described in human cells and
in plants, namely TASRs [10]. However, human TASRs are
more heterogeneous in size as compared to TTSa-RNAs.
Moreover, TASRs, whose 3′termini aligned with annotated
polyadenylation sites, map antisense to mRNA transcription.
In plants, TASRs are 23-24 nt in length and are bound by an
AGO protein [13], similar to TTSa-RNAs. However, like
human TASRs, plant TASRs seem to be a heterogeneous class
mapping on the sense, on the antisense strand or on both
strands of protein coding genes. Although we cannot exclude
that TTSa-RNAs are a subclass of TASR, because of
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Figure 1: TTSa-RNAs are associated with nuclear AGO1 and AGO2. (b) Coverage of AGO1- and AGO2-immunoprecipitated TTSa-RNAs
(HeLa S3) and FLAG:AGO2-immunoprecipitated TTSa-RNAs (HEK293) around GENCODE v25 annotated TTSs. Red and blue represent
sRNAs in the sense and antisense orientation with respect to gene transcription, respectively. (c) Overlap of genes giving rise to AGO1- and
AGO2-associated TTSa-RNAs. (d) Purified nuclei from HeLaS3 cells were extracted with a forcing urea/detergent buffer to yield a soluble
nuclear extract (SNE) and chromatin pellet extract (CPE). SNE and CPE were analyzed by Western blot for the presence of chromatin-
associated proteins (BAF-155 and H3) and AGO2. (e) RNA was isolated from HeLaS3 SNE and CPE and analyzed by qRT-PCR for the
detection of ACTB mRNA (as a non-chromatin-associated RNA), MALAT-1 (as a chromatin-associated RNA), miR-21, RNU44, and 5
selected TTSa-RNAs (n = 3). Synthetic ath-miR159a was added to SNE and CPE fractions before RNA isolation and subsequently used for
qRT-PCR normalization.
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differences in size, orientation, and mapping with respect to
polyadenylation sites, we believe that TTSa-RNAs are a
distinct class of sRNAs.
In our experimental design [6], we attained a sequencing
depth of 100 million reads per sample, which is substantially
higher than the depth employed by Valen and colleagues
[15]. This prompted us to investigate peculiar features of this
class of sRNAs in order to return a detailed characterization.
The estimated abundance of TTSa-RNAs is about
100 reads per million (RPM) in libraries generated
from the nuclear fraction of sRNAs in HeLaS3, reach-
ing about 300 RPM and 150 RPM in AGO1 and AGO2-
immunoprecipitated samples, respectively (Figure 1(b)). As
shown in Figure 1(c), TTSa-RNAs arise from 2822 genes,
and 37% of these genes give rise to TTSa-RNAs that are
loaded on both AGO1 and AGO2. More interestingly,
GO term analysis suggests that both genes giving rise to
AGO1- and AGO2-bound TTSa-RNAs are significantly
enriched for genes involved in cell cycle progression regu-
lation and DNA integrity checkpoints (Supplementary
Figure 1). A GO term analysis of genes giving rise to
IgG-immunoprecipitated sRNAs lying on TTS did not
highlight any significant enrichment for the same GO
terms (data not shown).
A parallel analysis on a sRNA-seq library obtained by
immunopurification of a FLAG-tagged AGO2 complexes
from a HEK293 cell line expressing a FLAG-tagged
AGO2 [22] yielded similar results, highlighting that TTSa-
RNAs are found in different human cell lines (Figures 1(a)
and 1(b)).
Not only TTSa-RNAs show a miRNA-like size that is a
specific feature for AGO loading but we also evidenced that
AGO2 and AGO1 physically interact with this class of sRNA
(Supplementary Figure 1A and B) by taking advantage of
PAR-CLIP-Seq datasets [35]. Indeed, PAR-CLIP shows
that TTSa-RNAs are associated with AGO2 and AGO1.
Interestingly, the abundance of TTSa-RNAs in PAR-CLIP
libraries is higher compared to the one observed in
noncrosslinked AGO IPs, suggesting that TTSa-RNAs are
directly associated with AGO proteins. Notably, only reads
containing one single mismatch with reference (mainly
T->C transitions, Supplementary Figure 1C and D) were
used to generate Supplementary Figure 1A and B, thus
ensuring that only bona fide AGO crosslinked molecules
are contributing to the signal observed.
Furthermore, we asked whether TTSa-RNA expression
levels are correlated with the abundance of the correspond-
ing mRNA. We looked at the correlation between gene
expression levels (as assessed by RNA-seq) of each gene
and the abundance of the TTSa-RNAs arising from TTSs
of the same gene in HeLaS3 cells for both AGO1 (R2<0.1)
and AGO2 (R2<0.1, n = 2). The R2 values observed do not
support any correlation between gene expression and
TTSa-RNA abundance.
Differently from Valen and colleagues [15], we showed
that TTSa-RNAs can be detected in libraries obtained from
nuclear extracts of HeLaS3 cells. We also investigated
whether TTSa-RNAs are recruited on chromatin. We
extracted HeLaS3 nuclei to separate soluble and loosely
bound material (soluble nuclear fraction (SNF)) from the
chromatin pellet (chromatin pellet extract (CPE)), which
retains tightly bound factors [21] (Figures 1(d) and 1(e)).
As a control of a chromatin-associated RNAs, we measured
MALAT [36]. Moreover, in order to provide evidence that
this procedure also preserves chromatin localization of
sRNAs, we verified that the small nucleolar RNA RNU44
was enriched in the CPE as compared to SNF. On the other
hand, we included in the analysis a soluble nuclear-
enriched mRNA, beta-actin (ACTB), and miR-21, which
has been previously detected not only in the cytosol but also
in the nucleus of human cells [37] (Figure 1(e)). We selected
5 abundant TTSa-RNAs arising from genes belonging to the
enriched GO categories (YWHAG,WEE1, PSMB1, CDKNA1,
and BUB3, see Table 1). We measured their abundance in
different nuclear fractions by qRT-PCR using specific
primers designed to selectively amplify sRNA molecules
and not their precursors [38]. TTSa-RNAs display a profile
of nucleoplasm/chromatin abundance very similar to the
one of ACTB mRNA and miR-21 rather than MALAT
and U44 (Figure 1(e)), arguing against their specific recruit-
ment on chromatin.
3.2. DICER Is Not Involved in TTSa-RNA Biogenesis. We
next focused on TTSa-RNAs biogenesis. Previously, it has
been speculated that the miRNA biogenesis pathway was
not involved in TTSa-RNA processing [15]. We aimed to
experimentally verify this hypothesis and we first investi-
gated whether TTSa-RNAs are processed by DICER. To
answer this question, we reanalyzed sRNA-seq libraries
derived from sRNAs bound to nuclear AGO2 in HCT116
and HCT116 DicerEX5 (a subclone of HCT116 cells in which
DICER has been impaired) cell lines [20] (Figures 2(a) and
2(b)) that we previously generated [6]. If DICER endonu-
cleolytic activity is required for TTSa-RNA biogenesis, one
would expect a dramatic global reduction of TTSa-RNA
abundance as it happens for miRNA [20] and for TSSa-
RNAs [6]. On the contrary, we found that AGO2-bound
TTSa-RNA abundance is considerably increased in
HCT116 DicerEX5 cells compared to parental HCT116 cells
(Figure 2(c)). To further validate these findings by qRT-
PCR, we analyzed the expression of the same five TTSa-
RNAs mentioned above by qRT-PCR in whole cell extracts
in HCT116 DicerEX5 cells as compared to parental cells.
None of the five TTSa-RNAs tested by qRT-PCR displayed
any decrease in HCT116 DicerEX5 cells (Figure 2(d)). In
agreement with NGS data, qPCR validation showed that
for some of the tested TTSa-RNAs, abundance increases in
HCT116 DicerEX5 compared to parental cells. Therefore, in
order to exclude that this increase was due to a higher
expression of the corresponding gene in HCT116 DicerEX5,
we took advantage of the GEO dataset GSE6427 which
reports mRNA expression levels in HCT116 and HCT116
DicerEX5 cells. As shown in Figure 2(e), the expression of
the YWHAG, WEE1, PSMB1, CDKNA1, and BUB3 mRNAs
is not affected by DICER ablation. We hypothesize that
higher levels of TTSa-RNAs in DICER hypomorphic cells
as compared to control, observed both in NGS data and in
qPCR validations, might be explained taking into account
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that lack of mature miRNA may promote loading on AGO1
and AGO2 of TTSa-RNAs, perhaps increasing their stability.
Overall, our data highlights that TTSa-RNA biogenesis is
not dependent on DICER.
Since it has been reported that miR-451 is processed in
a DICER-independent manner by AGO2 endonucleolytic
activity [39], we wondered whether TTSa-RNAs might be
processed by AGO2. In case AGO2 was required for
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TTSa-RNA biogenesis, AGO2 depletion should have
resulted in a major decrease of TTSa-RNA abundance in
whole cell extracts. We therefore profiled sRNAs in paren-
tal and AGO2KO HeLaS3 cells (obtained by genome edit-
ing mutation of AGO2 gene, Figure 2(e)) by sRNA-Seq
and we calculated TTSa-RNA abundance (Figure 2(g)).
Moreover, we evaluated the abundance of the five selected
TTSa-RNAs by qRT-PCR (Figure 2(h)). Both approaches
showed a slight decrease in TTSa-RNA abundance when
AGO2 is depleted. We concluded that even though
AGO2 is not required for TTSa-RNA biogenesis, it might
participate to TTSa-RNA stabilization, recapitulating what
was previously seen for miRNAs [40].
The fact that both DICER and AGO2 are dispensable for
TTSa-RNAs biogenesis is in agreement with our observation
that the regions flanking TTSa-RNAs are not biased toward
the formation of hairpin structures compared to randomly
picked genomic regions (data not shown).
3.3. Sequence Characteristics of TTSa-RNAs. We set out to
investigate whether any consensus nucleotide sequence could
be found within TTSa-RNAs or in the surrounding genomic
sequence. We could not identify a consensus sequence that
might provide any hints on TTSa-RNA biogenesis. However,
similarly to what was observed for other AGO-bound sRNAs
[41, 42], TTSa-RNAs have a bias against a G residue in
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the first position at 5′ end if compared to other AGO2-
bound sRNAs (Fisher Exact test p value< 2.2e-16) in all
libraries generated from AGO-immunoprecipitated samples
(Figure 3(a)). We noted that for all libraries, this bias is stron-
ger in TTSa-RNAs (3.25%) as compared to other AGO-
bound sRNAs (8.10%). This can be explained by the low
GC content in the regions upstream of human TTSs.
We also checked for any tailing at 3′ end of TTSa-RNAs.
We found that about 20% to 27% of TTSa-RNAs bound to
endogenous AGO1 and AGO2 displayed a short 3′ tail (1 to
3 nt in most cases). Importantly, 3′ tailing of both AGO1-
and AGO2-bound TTSa-RNAs displays a similar pattern.
Furthermore, 41% of the TTSa-RNAs bound to FLAG-
taggedAGO2 inHEK293Tdisplay a 3′ tail (Figure 3(b)). Since
it has been reported that miRNAs are 3′ tailed [43, 44], we
compared TTSa-RNAs and miRNA 3′ tailing in the same
samples. In both sRNAclasses, we found abundant monoade-
nylation and monouridylation. On the other hand, our data
highlight a significant (p value< 2.2E-16) increase of oligoA
tails (4 or more A) in TTSa-RNAs compared to miRNAs.
This finding suggests that mature polyadenylated mRNAs
might be the precursors of TTSa-RNAs. Although this
observation might suggest that TTSa-RNAs are mere
degradation by-products of mRNAs, the fact that they
arise specifically from the region of mRNAs immediately
upstream of polyA sites, the lack of any correlation with
corresponding mRNA abundance and the specific loading
on AGO proteins argue against this hypothesis. In
particular, it is difficult to conceive a general or wide-
spread mRNA degradation pathway leading to the specific
accumulation only of degradation fragments flanking polyA
sites. Therefore, we hypothesized that these sRNAs are not
simply mRNA degradation products but are specific, biolog-
ically generated species.
3.4. TTSa-RNAs Are Overexpressed in Human Tumors.
Up to now, the existence of sRNAs mapping around 3′
termini of mammalian genes was only reported for
cultured cell lines [10, 14, 15]. Therefore, we extended
our analysis of TTSa-RNAs to primary samples, and we
set out to look for TTSa-RNAs in sRNA NGS libraries
obtained from primary human samples. We searched
the SRA repository for datasets in which microRNA pro-
file was assessed by NGS. We retrieved five datasets suit-
able for TTSa-RNA analysis which contained publicly
available sRNA expression profiles in tumor samples
and matched control tissue. In all the five datasets ana-
lyzed, we could detect bona fide TTSa-RNAs displaying the
expect size profiles (Figure 4(a)). A small number of reads
mapping to TTS with a size of 35 nt were retrieved; therefore,
we only counted molecules shorter than 28nt as bona fide
TTSa-sRNAs. Since AGO-bound TTSa-RNAs in cell lines
do not correlate with the expression of the corresponding
mRNA, we asked whether bona fide TTSa-RNAs that we
identified in primary samples display any correlation with
mRNA expression. To answer this question, we took
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advantage of themRNA expression profiling available for two
of the five datasets. As depicted in Figure 4(b), in both cases,
we do not observe any significant correlation, highlighting
that not only in cultured cell lines but also in human tissues,
the amount of TTSa-RNAs is not correlated with the
expression of the corresponding gene.
Since deregulation of other sRNA classes has been
reported in human tumors [16, 19], we looked at TTSa-
RNAs expression in tumor tissues and matched controls. In
four out of five datasets analyzed, we found an increase of
TTSa-RNAs in tumor samples compared to matched healthy
tissues (Figure 4(c)). The lack of statistical significance of the
result obtained in endometrial cancer dataset is likely due to
the small number of samples in this dataset (n = 6). Interest-
ingly, we found that the expression of most TTSa-RNAs is
increased in cancer tissues, suggesting a general deregulation
of this class of RNAs rather than overexpression of a few
TTSa-RNAs (Supplementary Figure 3).
We concluded that TTSa-RNAs are not only detectable in
human primary tissues, but their expression also increases in
tumors. Accumulation of TTSa-RNAs in tumor samples
might reflect the previously reported deregulation of the
expression of RNAi components, such as DICER, AGO2,
and AGO1 in cancer cells [45]. In particular, downregulation
of DICER might impair miRNA processing, thus promoting
TTSa-RNA loading on AGO proteins. On the other hand,
AGO protein overexpression might stabilize TTSa-RNAs.
4. Conclusions
Here, we present a comprehensive study of sRNAs derived
from TTS of expressed genes in human cell lines and
primary tissues. Taking advantage of a sequencing depth of
100 million reads per sample, this characterization gets
insights into previously unknown details of biogenesis, local-
ization, sequence features, and expression of this new and
poorly studied class. Our data demonstrate that TTSa-
RNAs are a class of DICER-independent and AGO-bound
sRNAs, which display an oligoA tailing at 3′ end and which
are expressed not only in cultured cell lines but also in human
primary tissues. Even though the function of TTSa-RNAs
still remains elusive, the fact that genes that give rise to
TTSa-RNAs are involved in regulation of proliferation and
DNA damage response and that TTSa-RNAs are overex-
pressed in human tumors suggest that TTSa-RNA expression
is linked to tumorigenesis and they might be explored as
biomarker for diagnosis or prognosis of human malignancies
in the future.
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Supplementary Materials
Figure 1: AGO proteins are physically associated with
TTSa-RNAs. (a) Coverage of AGO2- and FLAG:AGO1-
PAR-CLIPPed TTSa-RNAs (HEK293) around GENCODE
v25 annotated TTSs. Red and blue represent sRNAs in
the sense and antisense orientation with respect to gene
transcription, respectively. (b) Mutation frequency of all
possible base transitions for AGO2- and FLAG:AGO1-
PAR-CLIPPed TTSa-RNAs. Figure 2: top-enriched GO
term of genes giving rise to TTSa-RNAs. GO term analysis
was performed for genes giving rise to HeLaS3 AGO1- and
AGO2-IPed TTSa-RNAs, HCT116 AGO2-IPed TTSa-RNAs,
and HEK293 FLAG:AGO2-IPed TTSa-RNAs. Figure 3: most
TTSa-RNAs increase their expression in cancer samples.
For each TTSa-RNA, the log2 ratio in cancer tissues
relative to matched controls was computed. The distribu-
tion of the values obtained is depicted for each dataset.
(Supplementary Materials)
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